Abstract Body

SHIVs are valuable tools that combine SIV and HIV genes in order to replicate within non-human primates. An ideal SHIV would be capable of infecting non-human primates while retaining antigenicity associated with a wild-type HIV. Since HIV-1 envelope glycoprotein (Env) confers cell tropism, it is necessary to utilize an Env that can infect non-human primate CD4+ T cells. Mutations have been found that allow Env to use macaque CD4 (mCD4) for infection. Two of these mutations, A204E and S375W, enable Env isolates to utilize mCD4, but differ in their antigenicity. As Env is a dynamic protein that can shift between closed/unbound and open/CD4-bound states, this suggests that there may be differences in the mechanisms that allow the two mutations to bind mCD4. Using a combination of structural and biophysical approaches, we aim to correlate Env structure with its interaction with mCD4 and neutralizing antibodies (nAbs).

A204E and S375W mutations were introduced into BG505 SOSIP.664 constructs. Negative stain electron microscopy (ns-EM) was used to characterize the structure of both constructs and will be used to image the trimers bound to antibody Fabs and mCD4. The structural nature of these Envs was also probed using hydrogen/deuterium-exchange mass spectrometry (HDX-MS) to provide insight into dynamic conformational differences between the mutants. HDX-MS will be used to characterize structural changes in response to CD4 binding. Lastly, biolayer interferometry (BLI) has been used to measure the binding affinities to nAbs and profile their antigenicity.

There were no obvious dynamic conformational shifts apparent using HDX-MS with both A204E and S375W. However, BLI and ns-EM suggest that A204E samples both an open and closed conformation in contrast to WT and S375W BG505 that maintain a closed conformation. The nAb 17b, which binds the open conformation, binds to A204E trimers but not to wild-type BG505 or S375W. Surprisingly, A204E also binds PGT145, which recognizes the closed structure, suggesting that it does in part adopt a closed conformation.

HIV Env variants encoding A204E and S375W differ in their dynamics and their antigenicity. While S375W maintains a closed conformation when unbound to CD4, A204E exhibits the ability to switch conformations without being CD4-bound. Thus, the antigenicity profile of A204E is altered compared to the wild type, while S375W is unchanged. Ongoing studies will define structural changes in response to CD4 binding.